Kyle Wierzbicki

Cornell University — United States

Medicine · Health Sciences

7h-index426citations29works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(20), Cancer Genomics and Diagnostics(12), MicroRNA in disease regulation(3), Cancer, Hypoxia, and Metabolism(3), Single-cell and spatial transcriptomics(3)

Publications29 total

Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults
Frontiers in Oncology·2025· 7 citedOpen Access
Identifying genomic signatures of recurrence in adrenocortical carcinoma after R0 resection
Surgery·2024· 1 cited
Supplementary Table S3A and S3B from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
2023Open Access
Supplementary Data from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
2023Open Access
Data from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
2023Open Access
Data from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
2023Open Access
Supplementary Table S3A and S3B from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
2023Open Access
Supplementary Data from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
2023Open Access
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
Neuro-Oncology·2022· 108 citedOpen Access
BIOM-28. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (cf-tDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201
Neuro-Oncology·2021Open Access
EPCT-03. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (CF-TDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201
Neuro-Oncology·2021Open Access
Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.
Journal of Clinical Oncology·2021
Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
Scientific Reports·2021· 56 citedOpen Access
DIPG-08. ELECTRONIC SEQUENCING PROVIDES OPTIMIZED QUANTIFICATION OF SERIAL, MULTI-GENE MOLECULAR RESPONSE IN THE CSF OF CHILDREN WITH HIGH-GRADE GLIOMA
Neuro-Oncology·2020Open Access
HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
Neuro-Oncology·2020· 3 citedOpen Access
Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
Clinical Cancer Research·2020· 48 citedOpen Access
Cross-platform Profiling of ctDNA Using ddPCR: Standardization of the Liquid Biopsy for Pediatric Diffuse Midline Glioma
2020Open Access
Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
Research Square (Research Square)·2020Open Access
Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
Journal of Clinical Investigation·2020· 67 citedOpen Access
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
Current Oncology Reports·2020· 2 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Carl Koschmann(23), Amy K. Bruzek(21), Rajen Mody(19), Hugh Garton(19), Evan Cantor(16), Patricia L. Robertson(16), Andrea Franson(15), Stefanie Stallard(14), Karthik Ravi(13), Ian Wolfe(12), Jack Wadden(11), Viveka Nand Yadav(10), Karin M. Muraszko(10), Rodrigo T. Cartaxo(9), Clarissa May Babila(9), Ashwath Muruganand(9), Jonathan Schwartz(9), Alyssa Paul(8), Leo Tunkle(8), Cormac O. Maher(8)